Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125812302 | 12581230 | 2 | F | 20150811 | 20160721 | 20160721 | 20160728 | EXP | CA-GILEAD-2016-0223752 | GILEAD | 69.00 | YR | E | M | Y | 0.00000 | 20160728 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125812302 | 12581230 | 1 | PS | TENOFOVIR DISOPROXIL FUMARATE. | TENOFOVIR DISOPROXIL FUMARATE | 1 | Unknown | 75 MG, QD | N | 21356 | 75 | MG | TABLET | QD | |||||
| 125812302 | 12581230 | 2 | SS | TENOFOVIR DISOPROXIL FUMARATE. | TENOFOVIR DISOPROXIL FUMARATE | 1 | Unknown | UNK | N | 21356 | TABLET | ||||||||
| 125812302 | 12581230 | 3 | SS | TENOFOVIR DISOPROXIL FUMARATE. | TENOFOVIR DISOPROXIL FUMARATE | 1 | Oral | 150 MG, QD | N | 21356 | 150 | MG | TABLET | QD | |||||
| 125812302 | 12581230 | 4 | SS | TENOFOVIR DISOPROXIL FUMARATE. | TENOFOVIR DISOPROXIL FUMARATE | 1 | Oral | 150 MG, QOD | N | 21356 | 150 | MG | TABLET | QOD | |||||
| 125812302 | 12581230 | 5 | SS | TENOFOVIR DISOPROXIL FUMARATE. | TENOFOVIR DISOPROXIL FUMARATE | 1 | Oral | 75 MG, QD | N | 21356 | 75 | MG | TABLET | QD | |||||
| 125812302 | 12581230 | 6 | C | 3TC | LAMIVUDINE | 1 | Unknown | UNK | 0 | ||||||||||
| 125812302 | 12581230 | 7 | C | 3TC | LAMIVUDINE | 1 | Unknown | UNK | 0 | ||||||||||
| 125812302 | 12581230 | 8 | C | 3TC | LAMIVUDINE | 1 | Unknown | UNK | 0 | ||||||||||
| 125812302 | 12581230 | 9 | C | 3TC | LAMIVUDINE | 1 | Unknown | UNK | 0 | ||||||||||
| 125812302 | 12581230 | 10 | C | ENTECAVIR. | ENTECAVIR | 1 | Oral | 1 MG, QD | 0 | 1 | MG | QD | |||||||
| 125812302 | 12581230 | 11 | C | DARUNAVIR | DARUNAVIR | 1 | Oral | 800 MG, QD | 0 | 800 | MG | QD | |||||||
| 125812302 | 12581230 | 12 | C | RITONAVIR. | RITONAVIR | 1 | Oral | 100 MG, QD | 0 | 100 | MG | QD | |||||||
| 125812302 | 12581230 | 13 | C | RALTEGRAVIR. | RALTEGRAVIR | 1 | Oral | 400 MG, BID | 0 | 400 | MG | BID | |||||||
| 125812302 | 12581230 | 14 | C | KIVEXA | ABACAVIR SULFATELAMIVUDINE | 1 | Oral | 1 DF, QD | 0 | 1 | DF | QD | |||||||
| 125812302 | 12581230 | 15 | C | ROSUVASTATIN. | ROSUVASTATIN | 1 | Oral | 10 MG, QD | 0 | 10 | MG | QD | |||||||
| 125812302 | 12581230 | 16 | C | ZOPICLONE | ZOPICLONE | 1 | Oral | 7.5 MG, QHS | 0 | 7.5 | MG | QD | |||||||
| 125812302 | 12581230 | 17 | C | CANDESARTAN | CANDESARTAN | 1 | Unknown | 4 MG, QD | 0 | 4 | MG | QD | |||||||
| 125812302 | 12581230 | 18 | C | GLYCOPYRRONIUM BROMIDE | GLYCOPYRRONIUM | 1 | Nasal | 50 UG, QD | 0 | 50 | UG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125812302 | 12581230 | 1 | Hepatitis B |
| 125812302 | 12581230 | 6 | Hepatitis B |
| 125812302 | 12581230 | 10 | Hepatitis B |
| 125812302 | 12581230 | 11 | HIV infection |
| 125812302 | 12581230 | 12 | HIV infection |
| 125812302 | 12581230 | 13 | HIV infection |
| 125812302 | 12581230 | 14 | HIV infection |
| 125812302 | 12581230 | 15 | Hypercholesterolaemia |
| 125812302 | 12581230 | 16 | Insomnia |
| 125812302 | 12581230 | 17 | Chronic kidney disease |
| 125812302 | 12581230 | 18 | Chronic obstructive pulmonary disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125812302 | 12581230 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125812302 | 12581230 | Angiopathy | |
| 125812302 | 12581230 | Renal impairment | |
| 125812302 | 12581230 | Viral load increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125812302 | 12581230 | 1 | 2009 | 0 | ||
| 125812302 | 12581230 | 2 | 200405 | 200709 | 0 | |
| 125812302 | 12581230 | 3 | 20080312 | 20080630 | 0 | |
| 125812302 | 12581230 | 4 | 20080701 | 20111221 | 0 | |
| 125812302 | 12581230 | 5 | 20111222 | 0 | ||
| 125812302 | 12581230 | 6 | 2003 | 200404 | 0 | |
| 125812302 | 12581230 | 7 | 200405 | 200709 | 0 | |
| 125812302 | 12581230 | 8 | 200710 | 200802 | 0 | |
| 125812302 | 12581230 | 9 | 200803 | 0 | ||
| 125812302 | 12581230 | 10 | 20071103 | 0 | ||
| 125812302 | 12581230 | 11 | 201206 | 0 | ||
| 125812302 | 12581230 | 12 | 200007 | 0 | ||
| 125812302 | 12581230 | 13 | 201308 | 0 | ||
| 125812302 | 12581230 | 14 | 2004 | 0 | ||
| 125812302 | 12581230 | 15 | 201605 | 0 |